Karyopharm Therapeutics to cut workforce by 20%; shares fall
** Drugmaker Karyopharm Therapeutics' shares KPTI.O down 15.8% at $4.21 premarket ** Company says in an SEC filing it is reducing its workforce by 20% ** Company expects its one-time expenses in connection with these actions to be immaterial ** Co says board is evaluating financing and strategic alternatives ** As of last close, stock down 50.7% YTD (Reporting by Siddhi Mahatole) ((siddhi.mahatole@thomsonreuters.com))
Recent news on Karyopharm Therapeutics
See all newsBrief: Karyopharm Therapeutics - Enters Forbearance Agreement And Waiver On Sept 10, 2026 - SEC Filing
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Karyopharm Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Karyopharm Q2 revenue falls as license revenue drops; expects funds to last into September
Karyopharm Therapeutics Inc. expected to post a loss of $1.28 a share - Earnings Preview